Author:
Minodora Andreea Spînu,Cîşleanu Diana,Nicolescu Anca,Voican Irina,Neagu Ana Maria,Neculcea Andreea,Mititelu Alina,Enache Cristina,Darabont Roxana,Mihalcea Diana,Stejara Mihai,Şerboiu Crenguţa,Vlădăreanu Ana Maria
Reference46 articles.
1. Cingam SR, Koshy NV. Acute Promyelocytic Leukemia. 2022. Treasure Island (FL): StatPearls Publishing; 2023. PMID: 29083825.
2. Larson RA, Gurbuxani S. Clinical manifestations, pathologic features, and diagnosis of acute promyelocytic leukemia in adults. UpToDate. 2022.
3. Lo-Coco F, Avvisati G, Vignetti M, Thiede C, Orlando SM, Iacobelli S, et al. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med. 2013; 369(2):111–121.
4. Iland HJ, Bradstock K, Supple SG, Catalano A, Collins M, Hertzberg M, et al. All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4). Blood. 2012;120(8):1570-1572.
5. Ferrel MN, Ryan JJ, Han FT. Acute myeloid leukemia causing acute thrombosis of the coronary arteries: a case report. J Med Case Reports. 2022;16(1):149.